ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 10 2020 - 7:00PM
Business Wire
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq:
ANIP) today announced that the Compensation Committee of ANI’s
Board of Directors granted a non-qualified inducement stock option
to purchase an aggregate of 179,643 shares of ANI’s common stock to
Nikhil Lalwani, President and Chief Executive Officer of ANI,
effective September 8, 2020.
The stock option was granted as an inducement material to Mr.
Lalwani entering into employment with ANI in accordance with Nasdaq
Listing Rule 5635(c)(4). The stock option was granted outside of
the Company’s Sixth Amended and Restated 2008 Stock Incentive Plan,
but except as set forth in the stock option agreement, is generally
subject to the same terms and conditions as apply to stock options
granted under the plan.
The stock option will vest with respect to 25% of the shares
underlying the stock option on each one-year anniversary of Mr.
Lalwani’s employment start date, subject to his continued service
to ANI through each relevant vesting date. Notwithstanding the
foregoing, the stock option will accelerate upon certain
terminations of employment, including within a certain period
following a change in control transaction. The stock option has a
ten-year term and an exercise price of $29.00 per share, which is
equal to the closing price of ANI’s common stock on September 8,
2020.
About ANI
ANI Pharmaceuticals, Inc. is an integrated specialty
pharmaceutical company developing, manufacturing, and marketing
branded and generic prescription pharmaceuticals. The Company's
targeted areas of product development currently include narcotics,
oncolytics (anti-cancers), hormones and steroids, and complex
formulations involving extended release and combination products.
For more information, please visit our website
www.anipharmaceuticals.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200910006035/en/
Investor Relations: Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793 E: lwilson@insitecony.com
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Aug 2024 to Sep 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Sep 2023 to Sep 2024